Gameto
Redefining women's health with innovative solutions
New York, United States · Founded 2020 · $100.0M raised
- Headquarters
- New York, New York
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- gametogen.com
- Total Funding
- $100.0M
- Last Round
- $44.0M Series CAug 2025
- Rounds
- 4
About
Gameto is a biotechnology company redefining female reproductive health through cell engineering. Its lead product Fertilo uses iPSC-derived granulosa-like cells to improve IVF outcomes, having reached Phase 3 clinical trials. Founded in 2020 by Dina Radenkovic Turner and Martin Varsavsky, Gameto has raised over $117 million and secured a $10 million ARPA-H award.
Summary
Gameto is a Life Sciences company based in New York, United States, founded in 2020. It has raised $100.0M in total across 4 rounds, most recently a $44.0M Series C round in Aug 2025. Investors include Future Ventures, Overwater Ventures and Two Sigma Ventures.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Future Ventures
3 rounds
Overwater Ventures
2 rounds
Two Sigma Ventures
2 rounds
RA Capital Management
2 rounds
Bold Capital Partners
3 rounds
Insight Partners
2 rounds
Ingeborg Investments
2 rounds
Arcadia Investment Partners
1 round
PAGS Group
1 round
Pontiva Healthcare Partners
1 round
Portfolia
1 round
Lux Capital
1 round
Plum Alley Investments
1 round
TA Ventures
1 round
Robert Nelsen
1 round
Anne Wojcicki
1 round
FJ Labs
1 round
SALT Fund
1 round
Jack Abraham
1 round
Dan Rose
1 round
Brian Armstrong
1 round
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.